Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using the new cholesterol guidelines in everyday practice.

D L Sprecher1, J P Frolkis

  • 1Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA. sprechd@ccf.org

Cleveland Clinic Journal of Medicine
|July 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Medical Bookshelf.

Postgraduate medicine·2016
Same author

A matter of trust: patient barriers to primary medication adherence.

Health education research·2014
Same author

Association between myeloperoxidase levels and risk of coronary artery disease.

JAMA·2001
Same author

Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

Circulation·2001
Same author

Targeting triglycerides as prognostic indicators and determining lowest values for patient benefit.

Current cardiology reports·2001
Same author

A novel test for the measurement of skin cholesterol.

Clinical chemistry·2001
Same journal

A 20-year-old woman with a 9-year history of shortness of breath.

Cleveland Clinic journal of medicine·2026
Same journal

A 70-year-old man with lower-extremity weakness and falls.

Cleveland Clinic journal of medicine·2026
Same journal

Treatment-refractory hypothyroidism: Don't just increase the dose.

Cleveland Clinic journal of medicine·2026
Same journal

In Reply: Beyond histologic improvement in MASH.

Cleveland Clinic journal of medicine·2026
Same journal

Comfort care: Creating a plan for hospitalized patients and their families.

Cleveland Clinic journal of medicine·2026
Same journal

Localized dead bone, a potential hint to an underlying condition.

Cleveland Clinic journal of medicine·2026
See all related articles

The updated National Cholesterol Education Program (NCEP) guidelines refine cardiovascular risk assessment. High-risk patients, including those with existing diseases or high coronary event risk, require specific lipid management strategies.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Previous National Cholesterol Education Program (NCEP) guidelines established risk-based cholesterol management.
  • The 2001 NCEP Adult Treatment Panel III (ATP III) guidelines represent a significant update.
  • Lipid management strategies are evolving based on comprehensive patient risk assessment.

Purpose of the Study:

  • To outline the key changes and recommendations in the third report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III).
  • To detail the refined methodology for cardiovascular risk assessment introduced in the 2001 guidelines.
  • To emphasize the importance of integrating lipid levels with patient risk status for effective treatment decisions.

Main Methods:

  • The guidelines classify patients into risk categories based on established cardiovascular diseases and calculated 10-year coronary event risk.

Related Experiment Videos

  • A refined scoring method is employed to determine a patient's 10-year risk of a coronary event.
  • Specific conditions, including coronary artery disease, diabetes mellitus, and peripheral vascular disease, are used to define the highest-risk group.

    • Main Results:

    • The 2001 NCEP ATP III guidelines introduce a more nuanced approach to cardiovascular risk stratification.
    • Patients with known coronary artery disease, diabetes, or other specific vascular diseases are categorized as highest risk.
    • A 10-year coronary event risk exceeding 20%, determined by a scoring method, also designates patients as highest risk.

    Conclusions:

    • The NCEP ATP III guidelines provide an updated framework for managing cholesterol and cardiovascular risk.
    • Accurate risk assessment is crucial for tailoring lipid-lowering therapies.
    • These guidelines aim to improve patient outcomes by optimizing the management of dyslipidemia in high-risk individuals.